Post

Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication

Gritstone bio has reported interim results from an ongoing Phase 1 study evaluating the company’s self-amplifying mRNA (samRNA) vaccine as …

Nexstim pilot study shows boost for depression symptoms

Nexstim has reported results from its pilot study on the use of accelerated intermittent theta burst stimulation (iTBS) protocol in …

Repare reports data from Phase I solid tumours therapy trial

Repare Therapeutics has reported initial proof of concept monotherapy data from the Phase I MYTHIC Module 1 trial of lunresertib …

Ventyx completes enrolment in ulcerative colitis and plaque psoriasis trials

Ventyx Biosciences has completed the enrolment of patients in the Phase II trial of VTX002 in ulcerative colitis and SERENITY …

VistaGen’s nasal spray could reduce menopausal hot flashes, new data suggests

A neuroactive nasal spray could reduce hot flashes during menopause, according to new data from VistaGen Therapeutics. In a 36-patient Phase …